Rising Prevalence Of Chronic Diseases Fuels Surge In The Medical Imaging Reagents Market: Pivotal Factor Influencing Medical Imaging Reagents Market Growth in 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Medical Imaging Reagents Market Size Growth Forecast: What to Expect by 2025?
In the recent past, the market size of medical imaging reagents has seen a robust growth. The market is expected to rise from $15.23 billion in 2024 to $16.31 billion in 2025, marking a compound annual growth rate (CAGR) of 7.1%. The past growth in this sector can be linked to factors such as a rising incidence of diseases, an ageing population, widening applications, approved regulations, along with strategic collaborations and partnerships.

How Will the Medical Imaging Reagents Market Size Evolve and Grow by 2029?
In the upcoming years, the market size for medical imaging reagents is predicted to experience substantial growth, anticipated to reach $21.31 billion in 2029 growing at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecasted period is expected to be driven by factors such as personalized medicine, an increased emphasis on early detection of diseases, the growing global prevalence of chronic illnesses, the expansion of point-of-care imaging, and the integration of theranostics. Key trends to watch out for in the forecast period include technological advancements, the rising incidence of chronic diseases, the use of diagnostic imaging in personalized medicine, the emergence and expansion of markets worldwide, and partnerships and collaborations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/medical-imaging-reagents-global-market-report

What Drivers Are Propelling the Growth of Medical Imaging Reagents Market Forward?
The rise in chronic disease incidence is projected to catalyze the expansion of the medical imaging reagents market. Chronic diseases are conditions that persist for at least a year, needing regular medical care and often becoming progressively worse. These types of diseases necessitate the use of medical imaging reagents for disease identification and detection by making visible the organs and structures affected. For example, the American Cancer Society, a voluntary organization based in the US, predicted in 2022 that there would be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the United States. In addition, the International Diabetes Federation, a Belgium-based coalition of national diabetes associations, reported in the IDF Diabetes Atlas Tenth Edition 2021, released in December of that year, that an estimated 537 million people aged 20-79 had diabetes in 2021. The number of diabetics worldwide is forecasted to rise to 643 million by 2030 and to 783 million by 2045. These escalating rates of chronic disease are fueling the expansion of the medical imaging reagents market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9917&type=smp

Which Emerging Trends Are Transforming the Medical Imaging Reagents Market in 2025?
One significant trend on the rise in the medical imaging reagents market is the focus on product innovations. To maintain their market standing, several prominent companies are concentrating on devising fresh solutions. In March 2023, for example, Aptamer Group PLC, a UK-based manufacturer of medical imaging reagents, introduced Optimer-Fc. This product consists of an Optimer binder linked to the Fc domain of an antibody, thereby facilitating the use of a variety of Optimer instruments in IHC applications. Optimer-Fc serves as a substitute for primary detecting antibody that suits existing workflows. IHC is a method to detect markers of diseases like cancer in cells. The development of this new suite of reagents will aid in improving research, diagnostics, and forensics by offering more accuracy and selectivity in detection. Thus, it will enable life scientists to investigate both new and known disease biomarkers.

What Are the Key Segments in the Medical Imaging Reagents Market?
The medical imaging reagents market covered in this report is segmented -

1) By Class: Contrast Reagents, Optical Reagents, Nuclear Reagents
2) By Technology: Nanoparticles, Fluorescent Dyes, Probes Radiopharmaceuticals, Fluorescent Proteins, Quantum Dots
3) By Modality: X-ray, CT Scan, Ultrasound, MRI Scan
4) By Application: Neurological Disorder, Cardiovascular Disorder, Cancer, Gastrointestinal Disorder, Musculoskeletal Disorder, Nephrological Disorder, Other Applications
5) By End User: Biotechnology Companies, Pharmaceutical Companies, Diagnostic Labs

Subsegments:
1) By Contrast Reagents: Iodine-Based Contrast Agents, Barium Sulfate Contrast Agents, Gadolinium-Based Contrast Agents
2) By Optical Reagents: Fluorescent Dyes, Luminescent Agents, Optical Probes
3) By Nuclear Reagents: Radioisotopes, Radiopharmaceuticals

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9917&type=smp

Who Are the Key Players Shaping the Medical Imaging Reagents Market's Competitive Landscape?
Major companies operating in the medical imaging reagents market include General Electric Company, Lantheus Holdings Inc., Thermo Fisher Scientific Inc., Bayer AG, Bracco SpA, Siemens AG, PerkinElmer Inc., Cardinal Health Inc., Shimadzu Corporation, Philips Healare, SA Laboratoires André Guerbet, Canon Medical Systems Corporation, Fujifilm Healare, Guerbet Group, Merck KGaA, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Toshiba Corporation, Hologic Inc., Carestream Health Inc., Curium Pharma, Nordion Inc., IBA Molecular, Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications, Jubilant Life Sciences Limited, Mallinckrodt Pharmaceuticals, Nihon Kohden Corporation, Mindray Medical International Limited, Samsung Medison Co. Ltd., Analogic Corporation

What Geographic Markets Are Powering Growth in the Medical Imaging Reagents Market?
North America was the largest region in the medical imaging reagents market in 2024. The regions covered in the medical imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9917

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.